HEM Pharma Inc. (KOSDAQ:376270)
22,400
+850 (3.94%)
At close: Nov 17, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 161.48 billion as of November 17, 2026. It is the 23,505th most valuable company in the world and the 898th biggest in South Korea. Its market cap has decreased by 18.70% in one year.
Market Cap
161.48B
Enterprise Value
173.18B
Revenue
16.14B
Global Rank
Country Rank
#898 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 161.48B, an increase of 41.43%. That is a compound annual growth rate of 18.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 161.48B | -50.69% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 219.37B |
| Vivozon Pharmaceutical | 180.49B |
| DAE HWA Pharmaceutical | 169.12B |
| GC WellBeing | 159.45B |
| Kyung Dong Pharmaceutical | 146.50B |
| CellBion | 146.35B |
| NOVAREX | 136.93B |
| Ahn-Gook Pharmaceutical | 108.31B |